Ivosidenib improves overall survival in IDH1-mutant advanced cholangiocarcinoma as compared to placebo
1. Patients receiving Ivosidenib had longer overall survival as compared to patients on placebo. 2. Quality of life measures favored ...
Tag: IDH1
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.